These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 3026407
1. Studies on the mechanism of action of the gastric microsomal (H+ + K+)-ATPase inhibitors SCH 32651 and SCH 28080. Scott CK, Sundell E, Castrovilly L. Biochem Pharmacol; 1987 Jan 01; 36(1):97-104. PubMed ID: 3026407 [Abstract] [Full Text] [Related]
2. Inhibition of H+K+ATPase by SCH 28080 and SCH 32651. Scott CK, Sundell E. Eur J Pharmacol; 1985 Jun 07; 112(2):268-70. PubMed ID: 2993001 [Abstract] [Full Text] [Related]
3. Effects of SCH 32651 on resting and stimulated acid secretion in guinea-pig isolated fundic mucosa. Barnett A, Chiu PJ, Tetzloff G. Br J Pharmacol; 1984 Sep 07; 83(1):75-82. PubMed ID: 6091829 [Abstract] [Full Text] [Related]
4. By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor. Simon WA, Keeling DJ, Laing SM, Fallowfield C, Taylor AG. Biochem Pharmacol; 1990 Jun 01; 39(11):1799-806. PubMed ID: 2160820 [Abstract] [Full Text] [Related]
12. Mechanism of gastric antisecretory effect of SCH 28080. Beil W, Hackbarth I, Sewing KF. Br J Pharmacol; 1986 May 01; 88(1):19-23. PubMed ID: 3011171 [Abstract] [Full Text] [Related]
13. Omeprazole, SCH 28080 and doxepin differ in their characteristics to inhibit H+/K+-ATPase driven proton accumulation by parietal cell membrane vesicles. Beil W, Staar U, Schünemann P, Sewing KF. Biochem Pharmacol; 1988 Dec 01; 37(23):4487-93. PubMed ID: 2849447 [Abstract] [Full Text] [Related]
14. Omeprazole, a specific inhibitor of gastric (H+-K+)-ATPase, is a H+-activated oxidizing agent of sulfhydryl groups. Im WB, Sih JC, Blakeman DP, McGrath JP. J Biol Chem; 1985 Apr 25; 260(8):4591-7. PubMed ID: 2985559 [Abstract] [Full Text] [Related]
15. The inhibitory effect of HOE 731 in isolated rabbit gastric glands. Herling AW, Becht M, Lang HJ, Scheunemann KH, Weidmann K, Scholl T, Rippel R. Biochem Pharmacol; 1990 Oct 15; 40(8):1809-14. PubMed ID: 2173590 [Abstract] [Full Text] [Related]
16. Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H+ + K+)-ATPase within the parietal cell. Wallmark B, Brändström A, Larsson H. Biochim Biophys Acta; 1984 Dec 19; 778(3):549-58. PubMed ID: 6095911 [Abstract] [Full Text] [Related]
17. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase. Fellenius E, Berglindh T, Sachs G, Olbe L, Elander B, Sjöstrand SE, Wallmark B. Nature; 1981 Mar 12; 290(5802):159-61. PubMed ID: 6259537 [Abstract] [Full Text] [Related]
19. Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione. Fujisaki H, Shibata H, Oketani K, Murakami M, Fujimoto M, Wakabayashi T, Yamatsu I, Yamaguchi M, Sakai H, Takeguchi N. Biochem Pharmacol; 1991 Jul 05; 42(2):321-8. PubMed ID: 1650210 [Abstract] [Full Text] [Related]
20. Effects of the enantiomers of lansoprazole (AG-1749) on (H+ + K+)-ATPase activity in canine gastric microsomes and acid formation in isolated canine parietal cells. Nagaya H, Inatomi N, Nohara A, Satoh H. Biochem Pharmacol; 1991 Oct 24; 42(10):1875-8. PubMed ID: 1660270 [Abstract] [Full Text] [Related] Page: [Next] [New Search]